For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, ...

The breakthrough, published Tuesday in the journal Cell, offers a promising new strategy to combat relapse, which occurs in ...

After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia ...

Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That ...

Now, a step forward in genetic testing could help doctors look deeper than ever before to predict a patient's future health.

FACE binds to CD71 on the T‑cell surface in CAR T cell preparation, and post-infusion, the same FACE molecules attach to CD71 ...

Have you ever asked how doctors help the body repair itself when a serious disease damages cells or tissues? Modern medicine ...

Chinese scientists, with the aim of enhancing leukemia treatment, have developed a kind of "double-sided tape" that helps the ...

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood ...

Debi Weiss thought her fatigue and weakness was a seasonal illness, but her condition quickly worsened.

The Alliance for Clinical Trials in Oncology has launched a new clinical trial for adults who need first-line therapy for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The ...